Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVATAR trial: Angiotensin II vs placebo in distributive shock
ChiCTR2500108297Phase 3Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Vasoplegia, septic shock, anaphylactic shock and 2 more comparing Angiotensin II arm with Placebo arm (2 arms). Primary endpoint: Proportion of subjects achieving blood pressure response at 3 hours. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
Angiotensin II
03
Conditions
Vasoplegiaseptic shockanaphylactic shockNeurogenic shockhypoadrenocorticism
Beyond the preview
Go deeper on ChiCTR2500108297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108297.